Categoría: Comunicados

Guía para solicitar fondos de CARES Act

In: Circulares, Comunicados, Noticias

Este enlace provee una guía sobre como solicitar la ayuda de CARES Act para los proveedores. Es tipo curso y tiene toda la información necesaria con teléfonos y correo electrónico para dudas. Estos fondos están bajo la jurisdicción de HHS directamente no de CMS. Este portal está muy claro y provee los recursos necesarios para solicitar los fondos y el proceso a seguir. Por favor compártanlo con todos los proveedores de PR.

By: Ray

CMS Reevaluates Accelerated Payment Program and Suspends Advance Payment Program

In: Circulares, Comunicados, Noticias

Today, the Centers for Medicare & Medicaid Services (CMS) announced that it is reevaluating the amounts that will be paid under its Accelerated Payment Program and suspending its Advance Payment Program to Part B suppliers effective immediately. The agency made this announcement following the successful payment of over $100 billion to healthcare providers and suppliers through these programs and in light of the $175 billion recently appropriated for healthcare provider relief payments.

CMS had expanded these temporary loan programs to ensure providers and suppliers had the resources needed to combat the beginning stages of the 2019 Novel Coronavirus (COVID-19). Funding will continue to be available to hospitals and other healthcare providers on the front lines of the coronavirus response primarily from the Provider Relief Fund. The Accelerated and Advance Payment (AAP) Programs are typically used to give providers emergency funding and address cash flow issues for providers and suppliers when there is disruption in claims submission or claims processing, including during a public health emergency or Presidentially-declared disaster.

Since expanding the AAP programs on March 28, 2020, CMS approved over 21,000 applications totaling $59.6 billion in payments to Part A providers, which includes hospitals. For Part B suppliers, including doctors, non-physician practitioners and durable medical equipment suppliers, CMS approved almost 24,000 applications advancing $40.4 billion in payments. The AAP programs are not a grant, and providers and suppliers are typically required to pay back the funding within one year, or less, depending on provider or supplier type. Beginning today, CMS will not be accepting any new applications for the Advance Payment Program, and CMS will be reevaluating all pending and new applications for Accelerated Payments in light of historical direct payments made available through the Department of Health & Human Services’ (HHS) Provider Relief Fund.

Significant additional funding will continue to be available to hospitals and other healthcare providers through other programs. Congress appropriated $100 billion in the Coronavirus Aid, Relief, and Economic Security (CARES) Act (PL 116-136) and $75 billion through the Paycheck Protection Program and Health Care Enhancement Act (PL 116-139) for healthcare providers. HHS is distributing this money through the Provider Relief Fund, and these payments do not need to be repaid.

The CARES Act Provider Relief Fund is being administered through HHS and has already released $30 billion to providers, and is in the process of releasing an additional $20 billion, with more funding anticipated to be released soon. This funding will be used to support healthcare-related expenses or lost revenue attributable to the COVID-19 pandemic and to ensure uninsured Americans can get treatment for COVID-19.

For more information on the CARES Act Provider Relief Fund and how to apply, visithhs.gov/providerrelief

For an updated fact sheet on the Accelerated and Advance Payment Programs, visit:https://www.cms.gov/files/document/Accelerated-and-Advanced-Payments-Fact-Sheet.pdf

###

Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.

By: Ray

CMS NEWS : OPENING UP AMERICA AGAIN

In: Circulares, Comunicados, Noticias

 Centers for Medicare & Medicaid Services (CMS) Recommendations Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase I The United States is experiencing an unprecedented public health emergency from the COVID-19 pandemic. Healthcare facilities in some areas are stretched to their limits of capacity, and surge areas have been needed to augment care for patients with COVID-19. To expand capacity to care for these patients and to conserve adequate staff and supplies, especially personal protective equipment (PPE), on March 18 the Centers for Medicare & Medicaid Services (CMS) recommended limiting non-essential care and expanding surge capacity into ambulatory surgical centers and other areas. However, CMS recognizes that at this time many areas have a low, or relatively low and stable incidence of COVID-19, and that it is important to be flexible and allow facilities to provide care for patients needing non-emergent, non-COVID-19 healthcare. In addition, as states and localities begin to stabilize, it is important to restart care that is currently being postponed, such as certain procedural care (surgeries and procedures), chronic disease care, and, ultimately, preventive care. Patients continue to have ongoing healthcare needs that are currently being deferred. Therefore, if states or regions have passed the Gating Criteria (symptoms, cases, and hospitals) announced on April 16, 2020, then they may proceed to Phase I. The Guidelines for Opening Up America Again can be found at the following link: https://www.whitehouse.gov/openingamerica/#criteria Maximum use of all telehealth modalities is strongly encouraged. However, for care that cannot be accomplished virtually, these recommendations — the first in a series of recommendations — may guide healthcare systems and facilities as they consider resuming in-person care of non-COVID-19 patients in regions with low incidence of COVID-19 disease. Non-COVID-19 care should be offered to patients as clinically appropriate and within a state, locality, or facility that has the resources to provide such care and the ability to quickly respond to a surge in COVID-19 cases, if necessary. Decisions should be consistent with public health information and in collaboration with state public health authorities. Careful planning is required to resume in-person care of patients requiring non-COVID-19 care, and all aspects of care must be considered — for example: 

  • Adequate facilities, workforce, testing, and supplies
  • Adequate workforce across phases of care (such as availability of clinicians, nurses, anesthesia,pharmacy, imaging, pathology support, and post-acute care)

The following recommendations aim to give healthcare facilities some flexibility in providing essential nonCOVID-19 care to patients without symptoms of COVID-19 in regions with low incidence of COVID-19. Healthcare systems or clinicians have flexibility to re-start clinically necessary care for patients with nonCOVID-19 needs or complex chronic disease management requirements in accordance with the following general considerations: 

General Considerations 

  • In coordination with State and local public health officials, evaluate the incidence and trends forCOVID-19 in the area where re-starting in-person care is being considered.
  • Evaluate the necessity of the care based on clinical needs. Providers should prioritizesurgical/procedural care and high-complexity chronic disease management; however, selectpreventive services may also be highly necessary.
  1. Consider establishing Non-COVID Care (NCC) zones that would screen all patients for symptoms of COVID-19, including temperature checks. Staff would be routinely screened as would others who will work in the facility (physicians, nurses, housekeeping, delivery and all people who would enter the area). 
  2. Sufficient resources should be available to the facility across phases of care, including PPE, healthy workforce, facilities, supplies, testing capacity, and post-acute care, without jeopardizing surge capacity. 

Personal Protective Equipment 

• Consistent with CDC’s recommendations for universal source control, CMS recommends that 

healthcare providers and staff wear surgical facemasks at all times. Procedures on the mucous membranes including the respiratory tract, with a higher risk of aerosol transmission, should be done with great caution, and staff should utilize appropriate respiratory protection such as N95 masks and face shields. 

  • Patients should wear a cloth face covering that can be bought or made at home if they do not already possess surgical masks. 
  • Every effort should be made to conserve personal protective equipment. 

https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/index.html 

Workforce Availability 

  • Staff should be routinely screened for symptoms of COVID -19 and if symptomatic, they should be tested and quarantined. Staff who will be working in these NCC zones should be limited to working in these areas and not rotate into “COVID-19 Care zones” (e.g., they should not have rounds in the hospital and then come to an NCC facility). 
  • Staffing levels in the community must remain adequate to cover a potential surge in COVID-19 cases. 

Facility Considerations 

  • In a region with a current low incidence rate, when a facility makes the determination to provide in-person, non-emergent care, the facility should create areas of NCC which have in place steps to reduce risk of COVID-19 exposure and transmission; these areas should be separate from other facilities to the degrees possible (i.e., separate building, or designated rooms or floor with a separate entrance and minimal crossover with COVID-19 areas). 
  • Within the facility, administrative and engineering controls should be established to facilitate social distancing, such as minimizing time in waiting areas, spacing chairs at least 6 feet apart, and maintaining low patient volumes. 
  • Visitors should be prohibited but if they are necessary for an aspect of patient care, they should be pre-screened in the same way as patients. 

Sanitation Protocols 

  • Ensure that there is an established plan for thorough cleaning and disinfection prior to using spaces or facilities for patients with non-COVID-19 care needs. 
  • Ensure that equipment such as anesthesia machines used for COVID-19 (+) patients are thoroughly decontaminated, following CDC guidelines. 

Supplies 

• Adequate supplies of equipment, medication and supplies must be ensured, and not detract for the community ability to respond to a potential surge. 

Testing Capacity 

  • All patients must be screened for potential symptoms of COVID-19 prior to entering the NCC facility, and staff must be routinely screened for potential symptoms as noted above. 
  • When adequate testing capability is established, patients should be screened by laboratory testing before care, and staff working in these facilities should be regularly screened by laboratory test as well. 

All facilities should continually evaluate whether their region remains a low risk of incidence and should be prepared to cease non-essential procedures if there is a surge. By following the above recommendations, flexibility can allow for safely extending in-person non-emergent care in select communities and facilities. 

By: Ray

COVID-19: Telehealth Video, Coinsurance and Deductible Waived & More

In: Comunicados, Eventos, Noticias

CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS)

Special Edition – Tuesday, April 7, 2020

 

New Video Available on Medicare Coverage and Payment of Virtual Services

CMS released a video providing answers to common questions about the Medicare telehealth services benefit. CMS is expanding this benefit on a temporary and emergency basis under the 1135 waiver authority and Coronavirus Preparedness and Response Supplemental Appropriations Act.

Video

Families First Coronavirus Response Act Waives Coinsurance and Deductibles for Additional COVID-19 Related Services

The Families First Coronavirus Response Act waives cost-sharing under Medicare Part B (coinsurance and deductible amounts) for Medicare patients for COVID-19 testing-related services. These services are medical visits for the HCPCS evaluation and management categories described below when an outpatient provider, physician, or other providers and suppliers that bill Medicare for Part B services orders or administers COVID-19 lab test U0001, U0002, or 87635.

Cost-sharing does not apply for COVID-19 testing-related services, which are medical visits that: are furnished between March 18, 2020 and the end of the Public Health Emergency (PHE); that result in an order for or administration of a COVID-19 test; are related to furnishing or administering such a test or to the evaluation of an individual for purposes of determining the need for such a test; and are in any of the following categories of HCPCS evaluation and management codes:

  • Office and other outpatient services
  • Hospital observation services
  • Emergency department services
  • Nursing facility services
  • Domiciliary, rest home, or custodial care services
  • Home services
  • Online digital evaluation and management services

Cost-sharing does not apply to the above medical visit services for which payment is made to:

  • Hospital Outpatient Departments paid under the Outpatient Prospective Payment System
  • Physicians and other professionals under the Physician Fee Schedule
  • Critical Access Hospitals (CAHs)
  • Rural Health Clinics (RHCs)
  • Federally Qualified Health Centers (FQHCs)

For services furnished on March 18, 2020, and through the end of the PHE, outpatient providers, physicians, and other providers and suppliers that bill Medicare for Part B services under these payment systems should use the CS modifier on applicable claim lines to identify the service as subject to the cost-sharing wavier for COVID-19 testing-related services and should NOT charge Medicare patients any co-insurance and/or deductible amounts for those services.

For professional claims, physicians and practitioners who did not initially submit claims with the CS modifier must notify their Medicare Administrative Contractor (MAC) and request to resubmit applicable claims with dates of service on or after 3/18/2020 with the CS modifier to get 100% payment.

For institutional claims, providers, including hospitals, CAHs, RHCs, and FQHCs, who did not initially submit claims with the CS modifier must resubmit applicable claims submitted on or after 3/18/2020, with the CS modifier to visit lines to get 100% payment.

Additional CMS actions in response to COVID-19, are part of the ongoing White House Task Force efforts. To keep up with the important work the Task Force is doing in response to COVID-19, visit www.coronavirus.gov. For a complete and updated list of CMS actions, and other information specific to CMS, please visit theCurrent Emergencies Website.

Guidance for Processing Attestations from Ambulatory Surgical Centers (ASCs) Temporarily Enrolling as Hospitals during the COVID-19 Public Health Emergency

CMS is providing needed flexibility to hospitals to ensure they have the ability to expand capacity and to treat patients during the COVID-19 public health emergency. As part of the COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers CMS is allowing Medicare-enrolled ASCs to temporarily enroll as hospitals and to provide hospital services to help address the urgent need to increase hospital capacity to take care of patients.

Guidance

COVID-19: Expanded Use of Ambulance Origin/Destination Modifiers

During the COVID-19 Public Health Emergency, Medicare will cover a medically necessary emergency and non-emergency ground ambulance transportation from any point of origin to a destination that is equipped to treat the condition of the patient consistent with state and local Emergency Medical Services (EMS) protocols where the services will be furnished. On an interim basis, we are expanding the list of destinations that may include but are not limited to:

  • Any location that is an alternative site determined to be part of a hospital, Critical Access Hospital (CAH), or Skilled Nursing Facility (SNF)
  • Community mental health centers
  • Federally Qualified Health Centers (FQHCs)
  • Rural health clinics (RHCs)
  • Physicians’ offices
  • Urgent care facilities
  • Ambulatory Surgery Centers (ASCs)
  • Any location furnishing dialysis services outside of an End-Stage Renal Disease (ESRD) facility when an ESRD facility is not available
  • Beneficiary’s home

CMS expanded the descriptions for these origin and destination claim modifiers to account for the new covered locations:

  • Modifier D – Community mental health center, FQHC, RHC, urgent care facility, non-provider-based ASC or freestanding emergency center, location furnishing dialysis services and not affiliated with ESRD facility
  • Modifier E – Residential, domiciliary, custodial facility (other than 1819 facility) if the facility is the beneficiary’s home
  • Modifier H – Alternative care site for hospital, including CAH, provider-based ASC, or freestanding emergency center
  • Modifier N – Alternative care site for SNF
  • Modifier P – Physician’s office
  • Modifier R – Beneficiary’s home

For the complete list of ambulance origin and destination claim modifiers see Medicare Claims Processing Manual Chapter 15, Section 30 A.

Lessons from The Front Lines: COVID-19

On April 3, CMS Administrator Seema Verma, Deborah Birx, MD, White House Coronavirus Task Force, and officials from the FDA, CDC, and FEMA participated in a call on COVID-19 Flexibilities. Several physician guests on the front lines presented best practices from their COVID-19 experiences. You can listen to the conversation here.

CMS COVID-19 Update Call Today

Tuesday, April 7 from 2 to 3 pm ET

Register for Medicare Learning Network events. Registration closes at 12pm ET.
CMS update on recent actions taken to address the COVID-19 public health emergency.
Target Audience: All Medicare fee-for-service providers and interested stakeholders.

By: Ray

CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19

In: Circulares, Comunicados, Noticias

The Centers for Medicare & Medicaid Services (CMS) is supporting clinicians on the front lines by getting red tape out of the way so the healthcare delivery system can focus on the 2019 Novel Coronavirus (COVID-19) response.  CMS is implementing additional extreme and uncontrollable circumstances policy exceptions and extensions for upcoming quality measure reporting and data submission deadlines for the following CMS programs:

Provider Programs 2019 Data Submission 2020 Data Submission
  • Quality Payment Program –

Merit-based Incentive Payment System (MIPS)

 Deadline extended from March 31, 2020 to April 30, 2020.

 

MIPS eligible clinicians who have not submitted any MIPS data by April 30, 2020 will qualify for the automatic extreme and uncontrollable circumstances policy and will receive a neutral payment adjustment for the 2021 MIPS payment year.

 CMS is evaluating options for providing relief around participation and data submission for 2020.
  • Medicare Shared Savings Program Accountable Care Organizations (ACOs)

 

Hospital Programs 2019 Data Submission 2020 Data Submission
  • Ambulatory Surgical Center Quality Reporting Program
 Deadlines for October 1, 2019 – December 31, 2019 (Q4) data submission optional.

 

If Q4 is submitted, it will be used to calculate the 2019 performance and payment (where appropriate). If data for Q4 is unable to be submitted, the 2019 performance will be calculated based on data from January 1, 2019 – September 30, 2019 (Q1-Q3) and available data.

 

 

 CMS will not count data from January 1, 2020 through June 30, 2020

(Q1-Q2) for performance or payment programs. Data does not need to be submitted to CMS for this time period.

 

* For the Hospital-Acquired Condition Reduction Program and the Hospital Value-Based Purchasing Program, if data from January 1, 2020 – March 31, 2020 (Q1) is submitted, it will be used for scoring in the program (where appropriate).
  • CrownWeb National ESRD Patient Registry and Quality Measure Reporting System
  • End-Stage Renal Disease (ESRD) Quality Incentive Program
  • Hospital-Acquired Condition Reduction Program
  • Hospital Inpatient Quality Reporting Program
  • Hospital Outpatient Quality Reporting Program
  • Hospital Readmissions Reduction Program
  • Hospital Value-Based Purchasing Program
  • Inpatient Psychiatric Facility Quality Reporting Program
  • PPS-Exempt Cancer Hospital Quality Reporting Program
  • Promoting Interoperability Program for Eligible Hospitals and Critical Access Hospitals
Post-Acute Care (PAC) Programs 2019 Data Submission 2020 Data Submission
  • Home Health Quality Reporting Program
 Deadlines for October 1, 2019 – December 31, 2019 (Q4) data submission optional.

 

If Q4 is submitted, it will be used to calculate the 2019 performance and payment (where appropriate).

 

 Data from January 1, 2020 through June 30, 2020 (Q1-Q2) does notneed to be submitted to CMS for purposes of complying with quality reporting program requirements.

 

* Home Health and Hospice Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey data from January 1, 2020 through September 30, 2020 (Q1-Q3) does not need to be submitted to CMS.

 

*For the Skilled Nursing Facility (SNF) Value-Based Purchasing Program, qualifying claims will be excluded from the claims-based SNF 30-Day All-Cause Readmission Measure (SNFRM; NQF #2510) calculation for Q1-Q2.

 
  • Hospice Quality Reporting Program
  • Inpatient Rehabilitation Facility Quality Reporting Program
  • Long Term Care Hospital Quality Reporting Program
  • Skilled Nursing Facility Quality Reporting Program
  • Skilled Nursing Facility Value-Based Purchasing Program

 

CMS is granting exceptions and extensions to assist health care providers and suppliers while they direct their resources toward caring for their patients and ensuring the health and safety of patients and staff. For those programs with data submission deadlines in April and May 2020, submission of those data will be optional based on the facility’s choice to report.  In addition, no data reflecting services provided January 1, 2020-June 30, 2020 will be used in CMS’ calculations for the Medicare quality reporting and value-based purchasing programs in order to reduce providers’ data collection and reporting burden as they are responding to the COVID-19 pandemic.

 

CMS recognizes that quality measure reporting may not be reflective of performance for measures such as cost, readmissions and patient experience during this time of emergency and seeks to hold organizations harmless for data during this period.  CMS will continue to monitor the situation and adjust reporting periods and submission deadlines accordingly. More detailed information about changes to each of these quality reporting programs will be provided soon.

Quality Payment Program

2019 MIPS Submission Deadline Extended: Submit 2019 Data by April 30, 2020

 

The 2019 Merit-based Incentive Payment System (MIPS) data submission deadline will be extended by 30 days to April 30, 2020.  If you have already submitted MIPS data or if you submit MIPS data by April 30, 2020, you will be scored and receive a MIPS payment adjustment based on the data you submit.  Many MIPS eligible clinicians have performed very well in the MIPS program in previous years. If you need to revise any data that has already been submitted you can still make changes by logging into qpp.cms.gov by the new deadline.

2019 MIPS Automatic Extreme and Uncontrollable Circumstances Policy Update

MIPS eligible clinicians who have not submitted any MIPS data by April 30, 2020 do not need to take any additional action to qualify for the automatic extreme and uncontrollable circumstances policy. These clinicians will be automatically identified and receive a neutral payment adjustment for the 2021 MIPS payment year. All four MIPS performance categories for these clinicians will be weighted at zero percent, resulting in a score equal to the performance threshold, and a neutral MIPS payment adjustment for the 2021 MIPS payment year. However, if a MIPS eligible clinician submits data on two or more MIPS performance categories, they will be scored and receive a 2021 MIPS payment adjustment based on their 2019 MIPS final score.

CMS will continue monitoring the developing COVID-19 situation and assess options to bring additional relief to clinicians and their staff so they can focus on caring for patients.

For More Information

Please reference the 2019 QPP Data Submission User Guide. CMS also has up to date information about its programs and response to COVID-19 on the  Current Emergencies page.

For Quality Payment Program questions you can contact 1-866-288-8292, Monday through Friday, 8:00 AM-8:00 PM ET or by e-mail at:QPP@cms.hhs.gov.

  • Customers who are hearing impaired can dial 711 to be connected to a TRS Communications Assistant.
By: Ray

CMS Coronavirus (COVID19) Partner Toolkit

In: Circulares, Comunicados, Noticias

Greetings to all providers in PR and the USVI.

In an effort to help providers stay informed about the COVID19, CMS has developed the following toolkit:  https://www.cms.gov/outreach-education/partner-resources/coronavirus-covid-19-partner-toolkit. Please, navigate the link and share with the most providers as you can. Your feedback is important to us during this emergency. Let me know should you have questions related this toolkit or any related concern. My contact information is below my signature for you to reach out.

By: Ray

CMS NEWS: President Trump Expands Telehealth Benefits for Medicare Beneficiaries During

In: Comunicados, Noticias

CMS NEWS

FOR IMMEDIATE RELEASE
March 17, 2020

Contact: CMS Media Relations
(202) 690-6145 | CMS Media Inquiries

 

 President Trump Expands Telehealth Benefits for Medicare Beneficiaries During

COVID-19 Outbreak

CMS Outlines New Flexibilities Available to People with Medicare

The Trump Administration today announced expanded Medicare telehealth coverage that will enable beneficiaries to receive a wider range of healthcare services from their doctors without having to travel to a healthcare facility. Beginning on March 6, 2020, Medicare—administered by the Centers for Medicare & Medicaid Services (CMS)—will temporarily pay clinicians to provide telehealth services for beneficiaries residing across the entire country.

“The Trump Administration is taking swift and bold action to give patients greater access to care through telehealth during the COVID-19 outbreak,” said Administrator Seema Verma. “These changes allow seniors to communicate with their doctors without having to travel to a healthcare facility so that they can limit risk of exposure and spread of this virus. Clinicians on the frontlines will now have greater flexibility to safely treat our beneficiaries.”

On March 13, 2020, President Trump announced an emergency declaration under the Stafford Act and the National Emergencies Act. Consistent with President Trump’s emergency declaration, CMS is expanding Medicare’s telehealth benefits under the 1135 waiver authority and the Coronavirus Preparedness and Response Supplemental Appropriations Act. This guidance and other recent actions by CMS provide regulatory flexibility to ensure that all Americans—particularly high-risk individuals—are aware of easy-to-use, accessible benefits that can help keep them healthy while helping to contain the spread of coronavirus disease 2019 (COVID-19).

Prior to this announcement, Medicare was only allowed to pay clinicians for telehealth services such as routine visits in certain circumstances. For example, the beneficiary receiving the services must live in a rural area and travel to a local medical facility to get telehealth services from a doctor in a remote location. In addition, the beneficiary would generally not be allowed to receive telehealth services in their home.

The Trump Administration previously expanded telehealth benefits. Over the last two years, Medicare expanded the ability for clinicians to have brief check-ins with their patients through phone, video chat and online patient portals, referred to as “virtual check-ins”. These services are already available to beneficiaries and their physicians, providing a great deal of flexibility, and an easy way for patients who are concerned about illness to remain in their home avoiding exposure to others.

A range of healthcare providers, such as doctors, nurse practitioners, clinical psychologists, and licensed clinical social workers, will be able to offer telehealth to Medicare beneficiaries. Beneficiaries will be able to receive telehealth services in any healthcare facility including a physician’s office, hospital, nursing home or rural health clinic, as well as from their homes.

Medicare beneficiaries will be able to receive various services through telehealth including common office visits, mental health counseling, and preventive health screenings. This will help ensure Medicare beneficiaries, who are at a higher risk for COVID-19, are able to visit with their doctor from their home, without having to go to a doctor’s office or hospital which puts themselves or others at risk. This change broadens telehealth flexibility without regard to the diagnosis of the beneficiary, because at this critical point it is important to ensure beneficiaries are following guidance from the CDC including practicing social distancing to reduce the risk of COVID-19 transmission. This change will help prevent vulnerable beneficiaries from unnecessarily entering a healthcare facility when their needs can be met remotely.

President Trump’s announcement comes at a critical time as these flexibilities will help healthcare institutions across the nation offer some medical services to patients remotely, so that healthcare facilities like emergency departments and doctor’s offices are available to deal with the most urgent cases and reduce the risk of additional infections. For example, a Medicare beneficiary can visit with a doctor about their diabetes management or refilling a prescription using telehealth without having to travel to the doctor’s office. As a result, the doctor’s office is available to treat more people who need to be seen in-person and it mitigates the spread of the virus.

As part of this announcement, patients will now be able to access their doctors using a wider range of communication tools including telephones that have audio and video capabilities, making it easier for beneficiaries and doctors to connect.

Clinicians can bill immediately for dates of service starting March 6, 2020. Telehealth services are paid under the Physician Fee Schedule at the same amount as in-person services. Medicare coinsurance and deductible still apply for these services. Additionally, the HHS Office of Inspector General (OIG) is providing flexibility for healthcare providers to reduce or waive cost-sharing for telehealth visits paid by federal healthcare programs.

Medicaid already provides a great deal of flexibility to states that wish to use telehealth services in their programs. States can cover telehealth using various methods of communication such as telephonic, video technology commonly available on smart phones and other devices. No federal approval is needed for state Medicaid programs to reimburse providers for telehealth services in the same manner or at the same rate that states pay for face-to-face services.

This guidance follows on President Trump’s call for all insurance companies to expand and clarify their policies around telehealth.

To read the Fact Sheet on this announcement visit: https://www.cms.gov/newsroom/fact-sheets/medicare-telemedicine-health-care-provider-fact-sheet

To read the Frequently Asked Questions on this announcement visit:https://www.cms.gov/files/document/medicare-telehealth-frequently-asked-questions-faqs-31720.pdf

This guidance, and earlier CMS actions in response to the COVID-19 virus, are part of the ongoing White House Task Force efforts. To keep up with the important work the Task Force is doing in response to COVID-19 click here https://protect2.fireeye.com/url?k=f2bd47f2-aee84ee1-f2bd76cd-0cc47adb5650-b1bc10a879080c7c&u=http://www.coronavirus.gov/. For information specific to CMS, please visit the Current Emergencies Website.

By: Ray

MLN Connects® | Edición especial – viernes 13 de marzo de 2020

In: Circulares, Comunicados, Noticias

COVID-19: Precio de pruebas, pruebas de laboratorio de diagnóstico, precios y códigos, y cobertura de EHB

  • COVID-19: Precio de pruebas, pruebas de laboratorio de diagnóstico, precios y códigos, y cobertura de EHB
  • Artículo de MLN Matters® de la actualización trimestral para tarifas fijas de laboratorio clínico y servicios de laboratorio sujetos a pago de cargo razonable
  • Cobertura de beneficios esenciales de salud (EHB)

COVID-19: Precio de pruebas, pruebas de laboratorio de diagnóstico, precios y códigos, y cobertura de EHB
El 12 de marzo, CMS publicó una hoja informativa external website PDF file(en inglés) con información relacionada al precio de los Centros para el Control y Prevención de Enfermedades (CDC) y de las pruebas que no son de los CDC.

Artículo de MLN Matters® de la actualización trimestral para tarifas fijas de laboratorio clínico y servicios de laboratorio sujetos a pago de cargo razonable

Un nuevo artículo (en inglés) de MLN Matters, MM 11681, acerca de la Artículo de MLN Matters® de la actualización trimestral para tarifas fijas de laboratorio clínico y servicios de laboratorio sujetos a pago de cargo razonable external website PDF fileestá disponible. Obtenga información sobre las pruebas de laboratorio de diagnóstico avanzado, los precios y los nuevos códigos. En la página 3, hacemos referencia a nuevos códigos COVID-19.

Cobertura de beneficios esenciales de salud (EHB)

El 12 de marzo, CMS emitió (en inglés) unas Preguntas frecuentes (FAQs) external website PDF fileacerca de EHB para asegurar que individuos, emisores, y estados tengan información clara de beneficios de cobertura para COVID-19. Esta acción esparto del esfuerzo Esta acción es parte del esfuerzo más amplio y continuo del Coronavirus Task Force de la Casa Blanca para garantizar que todos los americanos, particularmente aquellos con alto riesgo de complicaciones por el virus COVID-19, tengan acceso a los beneficios de salud que puedan ayudarlos a mantenerse saludables mientras se ayuda a contener la propagación de esta enfermedad.

Estas preguntas frecuentes y las acciones anteriores de CMS en respuesta al virus COVID-19 son parte de los esfuerzos en curso del Task Force de la Casa Blanca. Para mantenerse al día con el importante trabajo que el Grupo de Trabajo está haciendo en respuesta a COVID-19; visite la página web (en inglés) del CDC Enfermedad del Coronavirus 2019 external website.

Para información específica de CMS, por favor visite la página web (en inglés) Emergencias Actuales external website.

 

By: Ray

AVISO IMPORTANTE | Coronavirus (COVID-19)

In: Circulares, Comunicados, Noticias

16 de marzo de 2020

Ante los acontecimientos relacionados a la propagación mundial del Coronavirus (COVID-19), la seguridad y salud de los clientes y nuestra gente son prioridad para ASSERTUS.  Es por ello que, nos mantenemos atentos a las indicaciones oficiales del Centro para el Control y la Prevención de Enfermedades (CDC, por sus siglas en inglés) y el Gobierno de Puerto Rico. 

AL momento, una de las medidas más efectivas para prevenir la transmisión del virus en la comunidad es el distanciamiento social.  Esto reduce el ritmo de contagio, evita la sobrecarga del sistema de salud y ayuda a proteger el sistema inmunológico. 

Somos una empresa que da apoyo al sistema de salud de Puerto Rico, es nuestra responsabilidad y compromiso establecer medidas que permitan atender y mantener nuestras operaciones de manera continua. Con ello en mente hemos establecido protocolos para atender la seguridad de nuestros empleados, socios de negocios, clientes, proveedores y visitantes en general; incluyendo protocolos de higiene y sanitización de nuestras facilidades.   Sin embargo, como medida cautelar los adiestramientos grupales que se llevan a cabo en nuestras facilidades se estaránbrindando de manera remota tipo “webinar” comenzando el 26 de marzo de 2020, hasta nuevo aviso. 

Para ver los horarios y disponibilidad de estos adiestramientos en línea, puede acceder el siguiente enlace: https://mobile.assertus.com/es/calendario_de_adiestramientos/.  

El periodo de este protocolo puede extenderse según se estime necesario para salvaguardar la salud y seguridad de todos. 

Si usted tiene alguna inquietud o pregunta no dude en contactarnos vía telefónica al 787-622-2202 o escribiendo un correo electrónico a info@assertus.com. 

Nuestro equipo está preparado para apoyarle y orientarle sobre estos cambios. Seguiremos monitoreando el desarrollo del Coronavirus y las recomendaciones por parte de las instituciones pertinentes para la implementación de cualquier otra política adicional. 

Le invitamos a que nos siga por nuestros medios sociales; LinkedIn, Instagram, Facebook y página de Internet, donde informaremos cualquier cambio, política o protocolo adicional para la continuidad de nuestras operaciones y servicios.  

Agradecemos su confianza y reiteramos nuestro compromiso en ofrecer servicios con la más alta calidad, mientras que nos mantenemos en alerta al desarrollo de esta enfermedad novel.

Agradecemos su confianza y reiteramos nuestro compromiso en ofrecer servicios con la más alta calidad, mientras que nos mantenemos en alerta al desarrollo de esta enfermedad novel.

Ver comunicado original

By: Ray

CMS NEWS: Detailed Guidance to Providers about COVID-19

In: Circulares, Comunicados, Noticias

CMS NEWS

FOR IMMEDIATE RELEASE
March 10, 2020

Contact: CMS Media Relations
(202) 690-6145 | CMS Media Inquiries

 

  CMS Sends More Detailed Guidance to Providers about COVID-19
Healthcare workers in home health agencies and dialysis facilities are the latest group to receive important information on protecting staff and at-risk patients

Today, the Centers for Medicare & Medicaid Services (CMS) is supplementing its guidance to home health agencies and dialysis facilities to protect the health and safety of our nation’s patients and providers in response to the 2019 Novel Coronavirus (COVID-19) outbreak.

The memoranda were developed from frequently asked questions the agency has received about interacting with patients amid COVID-19. The guidance offers clear, actionable information to healthcare workers on the screening, treatment and transfer procedures to follow when interacting with patients. This action is part of the broader effort by the White House Task Force to ensure that all of our nation’s healthcare providers and patients – particularly those at high-risk of complications from COVID-19 – remain healthy while helping to contain the spread of the disease.

“We are arming our providers on the front lines with the information they need to remain safe, while giving quality care to their patients,” said CMS Administrator Seema Verma. “Today’s guidance will help providers identify patients who may have contracted the disease and minimize further transmission. It will also equip them to get these patients the medical care they need in order to recover.”

CMS is responsible for protecting beneficiaries who receive home healthcare services as well as those who receive treatment in dialysis facilities. Today’s guidance is an enhancement to the agency’s health and safety requirements and aims to help control and prevent the spread of infection. In particular, the new guidance advises all Medicare-enrolled dialysis facilities to identify high risk individuals prior to appointments or upon arrival, and immediately begin screening for fever or symptoms of a respiratory infection, such as a cough and sore throat, international travel within the last 14 days to restricted countries, and contact with someone with known or suspected COVID-19. Additionally, the guidance recommends screening visitors for potential exposure to the virus, gives detailed instructions for dealing with staff who have either been exposed or are showing signs of illness, and offers a list of frequently asked questions that include responses to help safely treat patients in this setting.

The guidance to home health agencies echoes recommendations set forth by the Centers for Disease Control and Prevention (CDC), with specific considerations of when it is safe to treat patients at home, when patients should be considered for hospitalization and recommendations for family member exposure, when evaluating and caring for patients with known or suspected COVID-19. CMS is recommending home health agencies remain vigilant, regularly monitor patients for any symptoms of the virus, and communicate effectively with patients, family members and other caregivers so that the entire care team understands a patient’s individual needs and goals of care. CMS’s guidance ends with a frequently asked question section offering answers to information that will ensure safe, quality care in the face of COVID-19.

To view, CMS’s guidance for home health providers, visit:https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and/guidance-infection-control-and-prevention-concerning-coronavirus-disease-2019-covid-19-home-health

To view, CMS’s guidance for dialysis facilities providers, visit:https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and/guidance-infection-control-and-prevention-coronavirus-disease-2019-covid-19-dialysis-facilities

This guidance, and earlier CMS actions in response to the COVID-19 virus, are part of the ongoing White House Task Force efforts. To keep up with the important work CMS is doing in response to COVID-19, please visit the Current Emergencies Website.

Summary of CMS Public Health Action on COVID-19 to date:

On March 9, 2020: CMS delivered guidance on the screening, treatment and transfer procedures healthcare workers must follow when interacting with patients to prevent the spread of COVID-19 in a hospice setting. CMS also issued additional guidance specific to nursing homes to help control and prevent the spread of the virus.

https://www.cms.gov/newsroom/press-releases/cms-issues-clear-actionable-guidance-providers-about-covid-19-virus

On March 9, 2020: CMS issued a press release highlighting the telehealth benefits in the agency’s Medicare program for use by patients and providers.  Expanded use of virtual care, such as virtual check-ins, are important tools for keeping beneficiaries healthy, while helping to contain the community spread of the COVID-19 virus.

https://www.cms.gov/newsroom/press-releases/telehealth-benefits-medicare-are-lifeline-patients-during-coronavirus-outbreak

On March 9, 2020:  CMS published guidance to hospitals with emergency departments (EDs) on patient screening, treatment and transfer requirements to prevent the spread of infectious disease and illness, including COVID-19. Medicare-participating hospitals are to follow both CDC guidance for infection control and Emergency Medical Treatment and Labor Act (EMTALA) requirements.

https://www.cms.gov/newsroom/press-releases/cms-issues-call-action-hospital-emergency-departments-screen-patients-coronavirus

March 6, 2020: CMS issued frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory test and other services related to the 2019-Novel Coronavirus (COVID-19). https://www.cms.gov/newsroom/press-releases/covid-19-response-news-alert-cms-issues-frequently-asked-questions-assist-medicare-providers

March 5, 2020: CMS issued a second Healthcare Common Procedure Coding System (HCPCS) code for certain COVID-19 laboratory tests, in addition to three fact sheets about coverage and benefits for medical services related to COVID-19 for CMS programs. https://www.cms.gov/newsroom/press-releases/cms-develops-additional-code-coronavirus-lab-tests

March 4, 2020: CMS issued a call to action to healthcare providers nationwide and offered important guidance to help State Survey Agencies and Accrediting Organizations prioritize their inspections of healthcare. https://www.cms.gov/newsroom/press-releases/cms-announces-actions-address-spread-coronavirus

February 13, 2020: CMS issued a new HCPCS code for providers and laboratories to test patients for COVID-19.  https://www.cms.gov/newsroom/press-releases/public-health-news-alert-cms-develops-new-code-coronavirus-lab-test

February 6, 2020: CMS gave CLIA-certified laboratories information about how they can test for SARS-CoV-2. https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/notification-surveyors-authorization-emergency-use-cdc-2019-novel-coronavirus-2019-ncov-real-time-rt

February 6, 2020: CMS issued a memo to help the nation’s healthcare facilities take critical steps to prepare for COVID-19.  https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/information-healthcare-facilities-concerning-2019-novel-coronavirus-illness-2019-ncov

By: Ray